Trials / Unknown
UnknownNCT01247714
Clinical Evaluation of a Specific Enteral Diet for Diabetics
Clinical Evaluation of a Specific Enteral Diet for Diabetics.A Randomised Cross-Over Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Vegenat, S.A. · Industry
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Not accepted
Summary
The hypothesis of the proposed trials is that the regular intake of a specific diet designed for enteral nutrition of type 2 diabetic patients results into a better nutritional status. Thus, the aim of the study is to scientifically evaluate the healthy effects of the administration of an enteral complete diet for diabetic patients (T-Diet plus Diabet).
Detailed description
This new complete diet has been carefully formulated, and incorporates functional ingredients based on: 1. A good gastrointestinal and metabolic tolerance of the product. 2. Beneficial outcomes in the nutritional status. 3. A good control of the glycaemic response and the lipidic profile, allowing an improvement of metabolic syndrome and insulin resistance indicators and hunger-satiety regulation. The experimental enteral product is a complete diet that includes, as carbohydrates, high-molecular maltodextrin, resistant maltodextrin, fructooligosaccharides and cellulose, and does not contain added fructose. Indeed, this product contains eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | T-Diet plus Standard | T-Diet plus Standard is a complete balanced protein and energy oral nutrition supplement, indicated for the dietary management of patients with related malnutrition. |
| DIETARY_SUPPLEMENT | T-Diet plus Diabet NP | T-Diet plus Diabet NP is a complete balanced oral nutrition supplement, indicated for the dietary management of diabetic patients or hyperglycemia related malnutrition. |
| DIETARY_SUPPLEMENT | Glucerna | GLUCERNA 1.0 CAL is a reduced-carbohydrate, modified-fat, fiber-containing formula clinically shown to blunt blood-glucose response in patients with abnormal glucose tolerance. |
| DIETARY_SUPPLEMENT | Novasource | Complete high protein diet for diabetic patients and hyperglycemic |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2014-12-01
- Completion
- 2015-05-01
- First posted
- 2010-11-24
- Last updated
- 2014-12-10
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01247714. Inclusion in this directory is not an endorsement.